Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.69 |
| ▸ | ANPEP | P15144 | 1/20 | 0.49 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | RAD52 | P43351 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | CA12 | O43570 | 3/20 | 0.44 |
| ▸ | CA6 | P23280 | 3/20 | 0.44 |
| ▸ | CA7 | P43166 | 3/20 | 0.44 |
| ▸ | CA9 | Q16790 | 3/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.44 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA3 | P07451 | 2/20 | 0.44 |
| ▸ | CA4 | P22748 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trientine SCHEMBL9064137 | 1.00 | ACE2 (0.69) | ACE2ANPEPERAP2HSD17B10CYP3A4 | |
| SCHEMBL6305650 | 1.00 | ACE2 (0.69) | ACE2ANPEPERAP2HSD17B10CYP3A4 | |
| SCHEMBL2138667 | 1.00 | ACE2 (0.69) | ACE2ANPEPERAP2HSD17B10CYP3A4 | |
| Piperazine SCHEMBL28286909 | 0.98 | ACE2 (0.67) | ACE2ANPEPERAP2HSD17B10CYP3A4 | |
| SCHEMBL302850 | 0.98 | ACE2 (0.72) | ACE2ANPEPERAP2HSD17B10CYP3A4 | |
| SCHEMBL26522670 | 0.94 | ACE2 (0.67) | ACE2ANPEPERAP2HSD17B10CYP3A4 | |
| SCHEMBL3975414 | 0.92 | ACE2 (0.70) | ACE2ANPEPERAP2HSD17B10CYP3A4 | |
| SCHEMBL4388203 | 0.92 | ACE2 (0.57) | ACE2ANPEPERAP2HSD17B10CYP3A4 | |
| Trientine SCHEMBL10749311 | 0.92 | ACE2 (0.57) | ACE2ANPEPERAP2HSD17B10CYP3A4 | |
| SCHEMBL5498811 | 0.90 | ACE2 (0.61) | ACE2ANPEPERAP2HSD17B10CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 624 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4416250-B1 | POLYAMIDE FUEL ADDITIVES | CHEVRON USA INC (US) | 2026-02-11 | — | — | EP | claimed |
| US-20240400920-A1 | POLYAMIDE FUEL ADDITIVES | CHEVRON U.S.A. INC. | 2024-12-05 | — | — | US | claimed |
| EP-4416250-A1 | POLYAMIDE FUEL ADDITIVES | Chevron U.S.A. Inc. (US) | 2024-08-21 | — | — | EP | claimed |
| US-20240067858-A1 | ALIPHATIC EPOXY RESIN CROSSLINKED POLYMERS FOR PRIMARY CEMENTING IN A BOREHOLE | SAUDI ARABIAN OIL COMPANY (SA) | 2024-02-29 | — | — | US | claimed |
| WO-2023062477-A1 | POLYAMIDE FUEL ADDITIVES | CHEVRON U.S.A. INC. (US) | 2023-04-20 | — | — | WO | claimed |
| US-20220177727-A1 | POLISHING SLURRY COMPOSITION FOR STI PROCESS | KCTECH CO., LTD. (KR) | 2022-06-09 | — | — | US | claimed |
| EP-2714611-B1 | FORMALDEHYDE-FREE SIZING COMPOSITION FOR FIBRES, IN PARTICULAR MINERAL FIBRES, AND RESULTING PRODUCTS | SAINT GOBAIN ISOVER (FR) | 2020-05-20 | — | — | EP | claimed |
| CN-105792942-B | Collector compositions and methods of making and using the same | 佐治亚-太平洋化工品有限公司 | 2019-04-16 | — | — | CN | claimed |
| US-10233115-B2 | Formaldehyde-free sizing composition for fibres, in particular mineral fibres, and resulting products | SAINT-GOBAIN ISOVER (FR) | 2019-03-19 | — | — | US | claimed |
| US-9511378-B2 | Collector compositions and methods for making and using same | GEORGIA-PACIFIC CHEMICALS LLC (US) | 2016-12-06 | — | — | US | claimed |
| US-20080004362-A1 | Hydroxyalkylated Polyalkylenepolyamine Composition, Method for Producing Same and Method for Producing Polyurethane Resin Using Such Hydroxyalkylated Polyalkylenepolyamine Composition | TOSOCH CORPORATION (JP) | 2008-01-03 | — | — | US | claimed |
| EP-1813599-A1 | HYDROXYALKYLATED POLYALKYLENEPOLYAMINE COMPOSITION, METHOD FOR PRODUCING SAME AND METHOD FOR PRODUCING POLYURETHANE RESIN USING SUCH HYDROXYALKYLATED POLYALKYLENEPOLYAMINE COMPOSITION | Tosoh Corporation (JP) | 2007-08-01 | — | — | EP | claimed |
| US-6878799-B2 | Acid functional polymer dispersants | KING INDUSTRIES, INC. (US) | 2005-04-12 | — | — | US | claimed |
| EP-1373387-A4 | NOVEL ACID FUNCTIONAL POLYMER DISPERSANTS | KING INDUSTRIES INC (US) | 2004-05-06 | — | — | EP | claimed |
| EP-1373387-A2 | NOVEL ACID FUNCTIONAL POLYMER DISPERSANTS | King Industries, Inc. (US) | 2004-01-02 | — | — | EP | claimed |
| US-20020169251-A1 | Novel acid functional polymer dispersants | KING INDUSTRIES, INC. | 2002-11-14 | — | — | US | claimed |
| WO-2002072639-A2 | NOVEL ACID FUNCTIONAL POLYMER DISPERSANTS | KING INDUSTRIES, INC. (US) | 2002-09-19 | — | — | WO | claimed |
| EP-0604097-B1 | Ink compositions | XEROX CORP (US) | 1999-10-13 | — | — | EP | claimed |
| EP-0604097-A1 | Ink compositions | XEROX CORPORATION (US) | 1994-06-29 | — | — | EP | claimed |
| US-5254159-A | Mixture of water, anionic dye and polyamine | XEROX CORPORATION (US) | 1993-10-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080004362-A1 | Hydroxyalkylated Polyalkylenepolyamine Composition, Method for Producing Same and Method for Producing Polyurethane Resin Using Such Hydroxyalkylated Polyalkylenepolyamine Composition | SRM, HRH3, HNMT | ACE2 3914/4885ANPEP 935/4885ERAP2 801/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.